Thursday, October 31, 2013

Israel strikes Russian weapons shipment in Syria

In this image taken from video obtained from the Shaam News Network, which has been authenticated based on its contents and other AP reporting, people try to extinguish a fire on the roof of a building, allegedly caused by shelling in Homs, Syria, Thursday, Oct. 31, 2013. President Bashar Assad's government met a key deadline in an ambitious plan to eliminate Syria's entire chemical weapons stockpile by mid-2014 and avoid international military action. (AP Photo/Shaam News Network via AP Video)







In this image taken from video obtained from the Shaam News Network, which has been authenticated based on its contents and other AP reporting, people try to extinguish a fire on the roof of a building, allegedly caused by shelling in Homs, Syria, Thursday, Oct. 31, 2013. President Bashar Assad's government met a key deadline in an ambitious plan to eliminate Syria's entire chemical weapons stockpile by mid-2014 and avoid international military action. (AP Photo/Shaam News Network via AP Video)







BEIRUT (AP) — Israeli warplanes attacked a shipment of Russian missiles inside a Syrian government stronghold, officials said Thursday, a development that threatened to add another volatile layer to regional tensions from the Syrian civil war.

The revelation came as the government of President Bashar Assad met a key deadline in an ambitious plan to eliminate Syria's entire chemical weapons stockpile by mid-2014 and avoid international military action.

The announcement by a global chemical weapons watchdog that the country has completed the destruction of equipment used to produce the deadly agents highlights Assad's willingness to cooperate, and puts more pressure on the divided and outgunned rebels to attend a planned peace conference.

An Obama administration official confirmed the Israeli airstrike overnight, but provided no details. Another security official said the attack occurred late Wednesday in the Syrian port city of Latakia and that the target was Russian-made SA-125 missiles.

The officials spoke on condition of anonymity because they were not authorized to publicly discuss the attack. There was no immediate confirmation from Syria.

Since the civil war in Syria began in March 2011, Israel has carefully avoided taking sides, but has struck shipments of missiles inside Syria at least twice this year.

The Syrian military, overstretched by the civil war, has not retaliated, and it was not clear whether the embattled Syrian leader would choose to take action this time. Assad may decide to again let the Israeli attack slide, particularly when his army has the upper hand on the battlefield inside Syria.

Israel has repeatedly declared a series of red lines that could trigger Israeli military intervention, including the delivery of "game-changing" weapons to the Syrian-backed Lebanese Hezbollah group.

Israel has never officially confirmed taking action inside Syria to avoid embarrassing Assad and sparking a potential response. But foreign officials say it has done so several times when Israeli intelligence determined that sophisticated missiles were on the move.

In January, an Israeli airstrike in Syria destroyed a shipment of advanced anti-aircraft missiles bound for Hezbollah, according to U.S. officials. And in May, it was said to have acted again, taking out a shipment of Iranian-made Fateh-110 missiles at a Damascus airport.

The Fateh-110s have advanced guidance systems that allow them to travel up to 200 miles (300 kilometers) per hour with great precision. Their solid-fuel propellant allows them to be launched at short notice, making them hard to detect and neutralize.

Israel has identified several other weapons systems as game changers, including chemical weapons, Russian-made Yakhont missiles that can be fired from land and destroy ships at sea, and Russian SA-17 anti-aircraft missiles. Israel's January airstrike is believed to have destroyed a shipment of SA-17s.

Syrian activists and opposition groups reported strong explosions Wednesday night that appeared to come from inside an air defense facility in Latakia. They said the cause of the blasts was not known.

The announcement Thursday that Syria had completed the destruction of equipment used to produce chemical weapons came one day ahead of a Nov. 1 deadline set by the Hague-based watchdog, the Organization for the Prohibition of Chemical Weapons.

But while some experts portrayed the step as a milestone, others said it has little impact as long as Syria still has its entire remaining stockpile of functioning chemical weapons.

"Only after those weapons have been destroyed or removed from Syrian control will the state be demilitarized," said David Reeths, director at HIS Jane's Consulting.

With the initial stage of verification and destruction of weapons machinery completed, the hard task now begins.

The executive committee of the Organization for the Prohibition of Chemical Weapons has until Nov. 15 to decide how best to permanently destroy Syria's chemical weapons program and its stockpile of deadly mustard gas, sarin and precursor chemicals.

It's not yet clear how and where the arsenal will be destroyed, but carrying out the work in Syria or transporting the chemical weapons out of the country for destruction elsewhere are both fraught with risks amid the ongoing civil war. The country is believed to have around 1,000 metric tons of chemical weapons.

Assad has so far met all required deadlines according to the strict timeline, demonstrating his willingness to go to great lengths to avoid international military action.

"This is a clear indication of the Syrian government's wish to cooperate and abide by its commitments," said Syrian lawmaker Issam Khalil. He said Syria knows "full well that the U.S. has not ceased its hostile policies toward Syria and will attempt to exploit any excuse — however small and inconsequential — to carry out a military strike against Syria."

The U.S.-Russian deal to destroy Syria's stockpile averted a U.S. military strike against the Syrian government that appeared certain in August, following a chemical weapons attack near Damascus that killed hundreds the U.S. blamed on Assad.

By making him a partner in implementing the disarmament deal, the agreement appears to have restored some of Assad's legitimacy while angering his opponents, who now balk at attending political transition talks the U.S. hopes will begin in Geneva in November.

No final date has been set for the talks, and there have been disagreements among opposition groups on whether to attend or not, and the conditions for taking part. Syria's main opposition group in exile, the Syrian National Coalition, postponed its general council meeting in Istanbul from Friday to Nov. 10, pending further discussions on the highly divisive talks.

U.N.-Arab League envoy Lakhdar Brahimi, currently in Damascus, has urged both sides to come to the talks without preconditions. But both have placed seemingly unrealistic conditions for attending.

At a Senate hearing in Washington on Thursday, Sen. John McCain said Assad, who was about to be toppled a year ago, has "turned the tide" while continuing to slaughter innocent civilians.

Fighting continued at a high pace across many parts of the country, including in the town of Safira, in northern Aleppo province. Experts say the town is home to a chemical weapons production facility, as well as storage sites.

Activists said troops were advancing Thursday in the town, capturing several neighborhoods and causing casualties on both sides.

Also on Thursday, the Syrian Observatory for Human Rights, a Britain-based Syria watchdog, said more than 120,000 people have been killed since the start of the country's conflict nearly three years ago. In July, the U.N. estimated 100,000 have died in the conflict since March 2011. It has not updated that figure since.

The violence underscored the dangers the chemical weapons' inspectors face as they race against tight deadlines in the midst of an ongoing civil war.

Earlier this week, the inspectors said they had completed their first round of verification work, visiting 21 of 23 sites declared by Damascus. They were unable to visit two sites because of security concerns, the inspectors said.

On Thursday, the chemical weapons agency said the two locations were, according to Syria, "abandoned and ... the chemical weapons program items they contained were moved to other declared sites, which were inspected."

It was not immediately clear if the facility in Safira was one of the two sites.

Commenting on the two sites, OPCW spokesman Michael Luhan said, "it was just deemed too risky." He told the AP that Syrian authorities were not able to offer the necessary security guarantees for inspectors to visit those sites.

He added, however, that the Syrian side provided "quite compelling documentary evidence" that equipment in one of the sites was moved to another location that inspectors did visit.

___

Corder reported from The Hague, Netherlands. Associated Press writers Robert Burns in Washington, Albert Aji in Damascus and Bassem Mroue in Beirut contributed to this report.

Associated PressSource: http://hosted2.ap.org/APDEFAULT/cae69a7523db45408eeb2b3a98c0c9c5/Article_2013-10-31-Syria/id-a138341aa4f04ab7a77aeaf1d441a5d4
Category: Captain America The Winter Soldier   mariano rivera   FIFA 14   Talk Like a Pirate Day   National Dog Day  

UTSA researchers develop prototype football kicking simulator

UTSA researchers develop prototype football kicking simulator


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

31-Oct-2013



[


| E-mail

]


Share Share

Contact: KC Gonzalez
kc.gonzalez@utsa.edu
210-458-7555
University of Texas at San Antonio



National Science Foundation-funded project aids football kickers through virtual training system




In football, kicking is a fundamental and vital part of the game. The few points a kicker scores can make a critical difference in the outcome of a game. To help improve a football kicker's performance, University of Texas at San Antonio (UTSA) mechanical and bioengineering professor Yusheng Feng and seven students have developed the prototype components for a football kicking simulator designed to be a real-time training tool.


Sponsored by the UTSA Center for Simulation, Visualization and Real-Time Prediction (SiViRT) with funding from the National Science Foundation (NSF), the Football Kicking Simulation & Human Performance Assessment is a virtual training system that uses real-time wireless feedback and computer sensing to measure football kicking mechanics data. It gives a kicker the ability to practice either on or off the field and receive the same kind of attention to detail he would experience at a training camp. Moreover, the quantitative data collected from the football dynamics and kicker's body motion can not only be used to predict the accuracy of a kick, but also give feedback to maximize the kicking power while mitigating the risk of injury.


In particular, the prototype provides quantifiable measures to improve a football kicker's consistency and reliability by:

  • Predicting the football's trajectory, incorporating real life factors such as drag, lift and wind factor
  • Sensing the pressure of the planted foot and angle of contact
  • Capturing the body motion of legs and joints through high speed cameras and video tracking
  • Displaying a realistic stadium environment by providing 3D visualization and surrounding sound
  • Providing dynamic and kinesiological analyses and simulations for coaches and players to design player-specific training programs

UTSA mechanical engineering undergraduate students Alyssa Schaefbauer, Cole Meyers, Jacob Kantor and Michael Lasch, kinesiology undergraduate student Ekow Acquaah, along with electrical and computer engineering graduate student Aaron Stout and computer science graduate student Ehren Biglari, have been developing and testing the virtual training system under the mentorship of Feng since February 2012.


"What sets our product apart from other kicking simulations is that we are using computer sensing and mathematical models to predict the football trajectory along with various training tools. It was designed specifically to be used for training rather than a form of entertainment, and it will be affordable," said Schaefbauer, the student team leader.


The group has been working with UTSA Football place-kicker Sean Ianno and assistant coach Perry Eliano to test the simulator and make necessary adjustments for ideal training. In order to consider the human factors in training and coaching, they are also incorporating feedback from faculty members in the UTSA Department of Health and Kinesiology.


"The simulator is an awesome idea. Although it is not a finished product yet, it has the potential to be on the cutting edge of technology and quite possibly could revolutionize how kickers train," said Ianno.


"The kicking simulator is an incredible project and something I believe can be very beneficial not only for our kickers, but for kickers across the country," stated Eliano. "I'm really humbled and thankful that the College of Engineering and their students who worked their tails off on this project chose us to be a part of it."


The research team has published two papers that were presented at the International Workshop on Computer Science in Sports and the Society for Modeling and Simulation International conference this summer.


"The football kicking simulator is a perfect example of how engineering and science can make improvements beyond the scientific arena, such as football, that are of interest to the greater community," said Feng. "It has been exciting to see these students develop into fine researchers who are determined to make a difference in society."


The research team has filed a patent application for the technology through the UTSA Office of Commercialization and Innovation and the team hopes to make the simulator commercially available for coaches and football teams to use as a training tool.


###

Established in August 2009 as a result of a $5 million grant from the National Science Foundation (NSF), the UTSA Center for Simulation, Visualization and Real-Time Prediction is a computation and visualization center that integrates high-performance computing into its activities which include imaging, visualization, modeling and simulation to help faculty and student researchers investigate structural reliability, particle flow, nanotechnology, biomechanics, computational neuroscience and cancer treatment simulation.



The SiViRT Center aims to shape UTSA's research environment by creating and supporting first-hand collaborative research and design experiences for both undergraduate and graduate students year-round. It is an interdisciplinary research center where students can apply their knowledge through teamwork. Learn more about the SiViRT Center at http://www.sivirt.utsa.edu.


For further information regarding the licensing of this or any UTSA technology, contact the UTSA Office of Commercialization and Innovation at oci@utsa.edu or call (210) 458-6963.


Connect online with UTSA at http://www.utsa.edu, http://www.facebook.com/utsa, http://www.twitter.com/utsa or http://www.youtube.com/utsa.


About UTSA

The University of Texas at San Antonio (UTSA) is an emerging Tier One research institution specializing in health, energy, security, sustainability, and human and social development. With nearly 29,000 students, it is the largest university in the San Antonio metropolitan region. UTSA advances knowledge through research and discovery, teaching and learning, community engagement and public service. The university embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property for Texas, the nation and the world.




[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




UTSA researchers develop prototype football kicking simulator


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

31-Oct-2013



[


| E-mail

]


Share Share

Contact: KC Gonzalez
kc.gonzalez@utsa.edu
210-458-7555
University of Texas at San Antonio



National Science Foundation-funded project aids football kickers through virtual training system




In football, kicking is a fundamental and vital part of the game. The few points a kicker scores can make a critical difference in the outcome of a game. To help improve a football kicker's performance, University of Texas at San Antonio (UTSA) mechanical and bioengineering professor Yusheng Feng and seven students have developed the prototype components for a football kicking simulator designed to be a real-time training tool.


Sponsored by the UTSA Center for Simulation, Visualization and Real-Time Prediction (SiViRT) with funding from the National Science Foundation (NSF), the Football Kicking Simulation & Human Performance Assessment is a virtual training system that uses real-time wireless feedback and computer sensing to measure football kicking mechanics data. It gives a kicker the ability to practice either on or off the field and receive the same kind of attention to detail he would experience at a training camp. Moreover, the quantitative data collected from the football dynamics and kicker's body motion can not only be used to predict the accuracy of a kick, but also give feedback to maximize the kicking power while mitigating the risk of injury.


In particular, the prototype provides quantifiable measures to improve a football kicker's consistency and reliability by:

  • Predicting the football's trajectory, incorporating real life factors such as drag, lift and wind factor
  • Sensing the pressure of the planted foot and angle of contact
  • Capturing the body motion of legs and joints through high speed cameras and video tracking
  • Displaying a realistic stadium environment by providing 3D visualization and surrounding sound
  • Providing dynamic and kinesiological analyses and simulations for coaches and players to design player-specific training programs

UTSA mechanical engineering undergraduate students Alyssa Schaefbauer, Cole Meyers, Jacob Kantor and Michael Lasch, kinesiology undergraduate student Ekow Acquaah, along with electrical and computer engineering graduate student Aaron Stout and computer science graduate student Ehren Biglari, have been developing and testing the virtual training system under the mentorship of Feng since February 2012.


"What sets our product apart from other kicking simulations is that we are using computer sensing and mathematical models to predict the football trajectory along with various training tools. It was designed specifically to be used for training rather than a form of entertainment, and it will be affordable," said Schaefbauer, the student team leader.


The group has been working with UTSA Football place-kicker Sean Ianno and assistant coach Perry Eliano to test the simulator and make necessary adjustments for ideal training. In order to consider the human factors in training and coaching, they are also incorporating feedback from faculty members in the UTSA Department of Health and Kinesiology.


"The simulator is an awesome idea. Although it is not a finished product yet, it has the potential to be on the cutting edge of technology and quite possibly could revolutionize how kickers train," said Ianno.


"The kicking simulator is an incredible project and something I believe can be very beneficial not only for our kickers, but for kickers across the country," stated Eliano. "I'm really humbled and thankful that the College of Engineering and their students who worked their tails off on this project chose us to be a part of it."


The research team has published two papers that were presented at the International Workshop on Computer Science in Sports and the Society for Modeling and Simulation International conference this summer.


"The football kicking simulator is a perfect example of how engineering and science can make improvements beyond the scientific arena, such as football, that are of interest to the greater community," said Feng. "It has been exciting to see these students develop into fine researchers who are determined to make a difference in society."


The research team has filed a patent application for the technology through the UTSA Office of Commercialization and Innovation and the team hopes to make the simulator commercially available for coaches and football teams to use as a training tool.


###

Established in August 2009 as a result of a $5 million grant from the National Science Foundation (NSF), the UTSA Center for Simulation, Visualization and Real-Time Prediction is a computation and visualization center that integrates high-performance computing into its activities which include imaging, visualization, modeling and simulation to help faculty and student researchers investigate structural reliability, particle flow, nanotechnology, biomechanics, computational neuroscience and cancer treatment simulation.



The SiViRT Center aims to shape UTSA's research environment by creating and supporting first-hand collaborative research and design experiences for both undergraduate and graduate students year-round. It is an interdisciplinary research center where students can apply their knowledge through teamwork. Learn more about the SiViRT Center at http://www.sivirt.utsa.edu.


For further information regarding the licensing of this or any UTSA technology, contact the UTSA Office of Commercialization and Innovation at oci@utsa.edu or call (210) 458-6963.


Connect online with UTSA at http://www.utsa.edu, http://www.facebook.com/utsa, http://www.twitter.com/utsa or http://www.youtube.com/utsa.


About UTSA

The University of Texas at San Antonio (UTSA) is an emerging Tier One research institution specializing in health, energy, security, sustainability, and human and social development. With nearly 29,000 students, it is the largest university in the San Antonio metropolitan region. UTSA advances knowledge through research and discovery, teaching and learning, community engagement and public service. The university embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property for Texas, the nation and the world.




[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Source: http://www.eurekalert.org/pub_releases/2013-10/uota-urd103113.php
Category: tlc   911 Memorial   Tom Harmon   auburn football   Pain and Gain  

Results of the HYBRID trial presented at TCT 2013

Results of the HYBRID trial presented at TCT 2013


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

31-Oct-2013



[


| E-mail

]


Share Share

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation



'Hybrid procedure' combining minimally invasive corornary artery bypass surgery (CABG) with percutaneous coronary intervention is feasible and safe compared with traditional CABG



SAN FRANCISCO, CA October 31, 2013 A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical trial. This is the first randomized study of the technique. These findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.


Hybrid coronary artery revascularization (HCR) as studied within this trial combined a minimally invasive left internal mammary artery bypass grafting to the left anterior descending artery (LAD) with percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation to other coronary arteries. Due to the lack of data from large, prospective randomized trials comparing HCR with standard surgical revascularization, HYBRID was designed as a feasibility study to assess the safety and efficacy of HCR in patients with multi-vessel coronary artery disease referred for standard coronary artery bypass grafting (CABG).


Two hundred consecutive patients, with angiographically confirmed multi-vessel coronary artery disease (CAD) involving the LAD and a critical (>70%) lesion in at least one major epicardial vessel (except LAD) amenable to both PCI and CABG, were randomized in a 1:1 fashion to HCR or standard surgical revascularization.


The primary objectives of this trial were to investigate the feasibility and safety of HCR. The feasibility assessment was defined both as the percentage of patients in the hybrid group that had a complete HCR procedure according to the study protocol and a percentage that had to be converted to standard CABG. The safety endpoint was the occurrence of MACE (major adverse cardiac events) such as death, myocardial infarction, stroke, repeat revascularization, major bleeding within the 12 month period after randomization.
In the trial, 93.9 percent of the patients in the hybrid group had the completed HCR procedure and 6.1 percent were converted to CABG.


At one year, 92.2 percent of the CABG group and 89.8 percent of the hybrid group were free from MACE. No strokes were reported in either group. The rate of death was 2.9 percent in the CABG group and 2.0 percent in the HCR group.


"This first randomized pilot study on hybrid coronary revascularization shows promising feasibility and safety results supporting the idea of hybrid coronary revascularization in patients with multi-vessel disease," said Michal Hawranek, MD, PhD, on behalf of the investigation team at the Silesian Center for Heart Disease in Zabrze, Poland.

###



The HYBRID trial was funded by the Ministry of Science and Higher Education of Poland. Dr. Hawranek reported no disclosures.


About CRF and TCT



The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. CRF is the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Celebrating its 25th anniversary this year, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit http://www.crf.org and http://www.tctconference.com.





[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Results of the HYBRID trial presented at TCT 2013


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

31-Oct-2013



[


| E-mail

]


Share Share

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation



'Hybrid procedure' combining minimally invasive corornary artery bypass surgery (CABG) with percutaneous coronary intervention is feasible and safe compared with traditional CABG



SAN FRANCISCO, CA October 31, 2013 A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical trial. This is the first randomized study of the technique. These findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.


Hybrid coronary artery revascularization (HCR) as studied within this trial combined a minimally invasive left internal mammary artery bypass grafting to the left anterior descending artery (LAD) with percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation to other coronary arteries. Due to the lack of data from large, prospective randomized trials comparing HCR with standard surgical revascularization, HYBRID was designed as a feasibility study to assess the safety and efficacy of HCR in patients with multi-vessel coronary artery disease referred for standard coronary artery bypass grafting (CABG).


Two hundred consecutive patients, with angiographically confirmed multi-vessel coronary artery disease (CAD) involving the LAD and a critical (>70%) lesion in at least one major epicardial vessel (except LAD) amenable to both PCI and CABG, were randomized in a 1:1 fashion to HCR or standard surgical revascularization.


The primary objectives of this trial were to investigate the feasibility and safety of HCR. The feasibility assessment was defined both as the percentage of patients in the hybrid group that had a complete HCR procedure according to the study protocol and a percentage that had to be converted to standard CABG. The safety endpoint was the occurrence of MACE (major adverse cardiac events) such as death, myocardial infarction, stroke, repeat revascularization, major bleeding within the 12 month period after randomization.
In the trial, 93.9 percent of the patients in the hybrid group had the completed HCR procedure and 6.1 percent were converted to CABG.


At one year, 92.2 percent of the CABG group and 89.8 percent of the hybrid group were free from MACE. No strokes were reported in either group. The rate of death was 2.9 percent in the CABG group and 2.0 percent in the HCR group.


"This first randomized pilot study on hybrid coronary revascularization shows promising feasibility and safety results supporting the idea of hybrid coronary revascularization in patients with multi-vessel disease," said Michal Hawranek, MD, PhD, on behalf of the investigation team at the Silesian Center for Heart Disease in Zabrze, Poland.

###



The HYBRID trial was funded by the Ministry of Science and Higher Education of Poland. Dr. Hawranek reported no disclosures.


About CRF and TCT



The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. CRF is the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Celebrating its 25th anniversary this year, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit http://www.crf.org and http://www.tctconference.com.





[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Source: http://www.eurekalert.org/pub_releases/2013-10/crf-rot_3103113.php
Category: Jenna Jameson   Ray Rice   russell wilson   FXX   Lucas Cruikshank  

iPad Air goes on sale in Australia, Hong Kong and China via online stores

Right on cue, the iPad Air has gone on sale in Australia, China and Hong Kong via each nations respective Apple stores. So far shipping is looking good for Australia and China, with shipping within 24 hours currently available across all models. In Hong Kong, shipping is 1-2 weeks at the moment.

So, iPad day has begun for some of us, so if you're somewhere where the iPad Air has now gone on sale and you bought one, drop us a line in the comments and tell us what you got, or jump into the iMore Forums and carry on the discussion! Better still, if you're about to head out somewhere to get in line, then do it with iMore!

iPad Air

iPad Air
Apple's full-sized iPad gets slimmed down. Features include:

Complete preview >

Released
November, 2013

Alternatives
Retina iPad mini, iPad 2

Replacements
iPad Air 2 (iPad 6)
Fall, 2014

Resources
Buyers guide
Help forum


    






Source: http://feedproxy.google.com/~r/TheIphoneBlog/~3/6SG_dhqC_4A/story01.htm
Category: kaley cuoco   Dallas Latos   aaron hernandez   Lady Gaga Vma   Ichiro Suzuki  

Make a Spooky Smoke Waterfall Using Sticky Notes and Fire

Make a Spooky Smoke Waterfall Using Sticky Notes and Fire

Here's an awesome experiment you can try if you're looking for a last minute way to decorate your cubicle or house for Halloween. It's particularly great if you have one of those tiny relaxing waterfalls at your disposal, since replacing the water with cascading smoke is sure to have everyone thinking you're some kind of wizard—despite your costume.

Read more...


    






Source: http://feeds.gawker.com/~r/gizmodo/full/~3/mLLvY38abrc/make-a-spooky-smoke-waterfall-using-sticky-notes-and-fi-1454993631
Related Topics: NBA   Olivia Culpo   tom hanks   Jenna Wolfe   amber heard  

Women under 60 with diabetes at much greater risk for heart disease

Women under 60 with diabetes at much greater risk for heart disease


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

31-Oct-2013



[


| E-mail

]


Share Share

Contact: Patrick Smith
psmith88@jhmi.edu
410-955-8242
Johns Hopkins Medicine







Results of a Johns Hopkins study published today in the journal Diabetes Care found that young and middle-aged women with type 2 diabetes are at much greater risk of coronary artery disease than previously believed.


Generally, women under 60 are at far less risk for coronary artery disease than men of the same age. But among women of that age who have diabetes, their risk of heart disease increases by up to four times, making it roughly equal to men's risk of this same form of heart disease.


"Our findings suggest that we need to work harder to prevent heart disease in women under 60 who have diabetes," says Rita Rastogi Kalyani, M.D., M.H.S., endocrinologist at the Johns Hopkins University School of Medicine and lead study author. "This study tells us that women of any age who have diabetes are at a high risk for coronary artery disease."


While men generally have a higher incidence of heart disease than women, the study found that diabetes had little or no effect on men's heart disease risk.
Kalyani said the new study is believed to be the first to focus specifically on gender differences in coronary artery disease among younger and middle-aged people with diabetes.


For the research, she and her colleagues analyzed data from more than 10,000 participants in three widely regarded studies: the GeneSTAR Research Program, the Multi-Ethnic Study of Atherosclerosis and the National Health and Nutrition Examination Survey (NHANES) III. None of the participants had a history of heart disease. All three studies yielded similar gender differences in rates of diabetes and the risk of developing heart disease.


"Our study adds to growing evidence that gender differences exist in the risk of coronary artery disease brought on by diabetes," Kalyani says.


Interestingly, in both women and men, these findings were unrelated to differences in obesity and other traditional cardiovascular risk factors such as high blood pressure, cholesterol and smoking.


Kalyani and her colleagues offer several possible explanations for the increased risk. There may be distinct genetic and hormonal factors related to the development of heart disease by gender. Differences in adherence to heart-healthy lifestyle behaviors, compliance and treatment of cardiovascular treatments between genders are also possible but need to be further investigated, Kalyani says. Also, the relationship of diabetes duration and glucose control to risk of heart disease remains unclear.


###

In addition to Kalyani, the study's authors are Mario Lazo, M.D.; Pamelo Ouyang, M.B.B.S.; Karinne Chevalier, M.S.; Frederick Brancati, M.D., M.H.S.; Diane Becker, Sc.D., M.P.H.; and Dhananjay Vaidya, Ph.D., M.P.H., of the Johns Hopkins University School of Medicine, as well as Evrim Turkbey, M.D., of Radiology and Imaging Sciences at the National Institutes of Health Clinical Center.



About Johns Hopkins Medicine



Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.




Media Contacts: Patrick Smith

410-955-8242; psmith88@jhmi.edu or

Helen Jones

410-502-9422; hjones49@jhmi.edu


[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Women under 60 with diabetes at much greater risk for heart disease


[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:

31-Oct-2013



[


| E-mail

]


Share Share

Contact: Patrick Smith
psmith88@jhmi.edu
410-955-8242
Johns Hopkins Medicine







Results of a Johns Hopkins study published today in the journal Diabetes Care found that young and middle-aged women with type 2 diabetes are at much greater risk of coronary artery disease than previously believed.


Generally, women under 60 are at far less risk for coronary artery disease than men of the same age. But among women of that age who have diabetes, their risk of heart disease increases by up to four times, making it roughly equal to men's risk of this same form of heart disease.


"Our findings suggest that we need to work harder to prevent heart disease in women under 60 who have diabetes," says Rita Rastogi Kalyani, M.D., M.H.S., endocrinologist at the Johns Hopkins University School of Medicine and lead study author. "This study tells us that women of any age who have diabetes are at a high risk for coronary artery disease."


While men generally have a higher incidence of heart disease than women, the study found that diabetes had little or no effect on men's heart disease risk.
Kalyani said the new study is believed to be the first to focus specifically on gender differences in coronary artery disease among younger and middle-aged people with diabetes.


For the research, she and her colleagues analyzed data from more than 10,000 participants in three widely regarded studies: the GeneSTAR Research Program, the Multi-Ethnic Study of Atherosclerosis and the National Health and Nutrition Examination Survey (NHANES) III. None of the participants had a history of heart disease. All three studies yielded similar gender differences in rates of diabetes and the risk of developing heart disease.


"Our study adds to growing evidence that gender differences exist in the risk of coronary artery disease brought on by diabetes," Kalyani says.


Interestingly, in both women and men, these findings were unrelated to differences in obesity and other traditional cardiovascular risk factors such as high blood pressure, cholesterol and smoking.


Kalyani and her colleagues offer several possible explanations for the increased risk. There may be distinct genetic and hormonal factors related to the development of heart disease by gender. Differences in adherence to heart-healthy lifestyle behaviors, compliance and treatment of cardiovascular treatments between genders are also possible but need to be further investigated, Kalyani says. Also, the relationship of diabetes duration and glucose control to risk of heart disease remains unclear.


###

In addition to Kalyani, the study's authors are Mario Lazo, M.D.; Pamelo Ouyang, M.B.B.S.; Karinne Chevalier, M.S.; Frederick Brancati, M.D., M.H.S.; Diane Becker, Sc.D., M.P.H.; and Dhananjay Vaidya, Ph.D., M.P.H., of the Johns Hopkins University School of Medicine, as well as Evrim Turkbey, M.D., of Radiology and Imaging Sciences at the National Institutes of Health Clinical Center.



About Johns Hopkins Medicine



Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.




Media Contacts: Patrick Smith

410-955-8242; psmith88@jhmi.edu or

Helen Jones

410-502-9422; hjones49@jhmi.edu


[ Back to EurekAlert! ]

[


| E-mail


Share Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.




Source: http://www.eurekalert.org/pub_releases/2013-10/jhm-wu6103113.php
Category: Daylight Savings Time 2013   Revolt TV   world trade center   aaron hernandez   Galaxy Note 3